For research use only. Not for therapeutic Use.
Ocinaplon (Cat.No:I010950) is a medication that belongs to the class of selective GABA-A receptor modulators. It was initially developed as an anxiolytic and muscle relaxant. However, clinical trials for its potential use in anxiety and insomnia were discontinued due to concerns over side effects. Ocinaplon is no longer in active development as a therapeutic agent.
| Catalog Number | I010950 |
| CAS Number | 96604-21-6 |
| Synonyms | 2-Pyridinyl[7-(4-pyridinyl)pyrazolo[1,5-a]pyrimidin-3-yl]methanone |
| Molecular Formula | C17H11N5O |
| Purity | ≥95% |
| Target | Neuronal Signaling |
| Solubility | Soluble to 100 mM in 2eq.HCl and to 10 mM in DMSO |
| Storage | Store at +4C |
| IUPAC Name | pyridin-2-yl-(7-pyridin-4-ylpyrazolo[1,5-a]pyrimidin-3-yl)methanone |
| InChI | InChI=1S/C17H11N5O/c23-16(14-3-1-2-7-19-14)13-11-21-22-15(6-10-20-17(13)22)12-4-8-18-9-5-12/h1-11H |
| InChIKey | OQJFBUOFGHPMSR-UHFFFAOYSA-N |
| SMILES | C1=CC=NC(=C1)C(=O)C2=C3N=CC=C(N3N=C2)C4=CC=NC=C4 |
